Effects of sodium intake, furosemide, and infusion of atrial natriuretic peptide on the urinary and metabolic clearances of arginine vasopressin in normal subjects.
Arginine vasopressin (AVP) and atrial natriuretic peptide (ANP) have important influences on water and electrolyte metabolism, and studies on the interactions between these hormones may have important implications. We have investigated the effects of sodium intake, furosemide, and infusion of ANP on the urinary and metabolic (nonurinary) clearances of AVP in hydrated normal subjects. On a high sodium diet there was an increase in urine volume, sodium excretion, osmolal clearance, plasma ANP concentration, and urinary clearance and fractional excretion of AVP, with a decrease in PRA. The infusion of furosemide increased urine volume, sodium excretion, osmolal clearance, and PRA, but decreased circulating ANP levels and urinary clearance and fractional excretion of AVP. Since there was a positive correlation between circulating ANP and urinary clearance of AVP in these experiments, we infused human alpha ANP in physiological amounts and found increases in the urinary and metabolic (nonurinary) clearances of AVP. The changes in urinary clearance of AVP in all three experiments occurred even in relation to creatinine clearance. These observations demonstrate that urinary clearance of AVP does not correlate with urine volume, sodium or solute excretion, or PRA. The observations support a physiological role for ANP in modulating the renal action of AVP, probably at the level of the renal tubules, and indicate a need for caution when using plasma or urinary AVP as an indicator of AVP release from the neurohypophysis.
Moses
A M
AM
Veterans Administration Medical Center, Syracuse, New York.
Jones
C
C
Yucha
C B
CB
D000328:Adult; D001127:Arginine Vasopressin / Q000493:pharmacokinetics*; D009320:Atrial Natriuretic Factor / Q000008:administration & dosage* / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D003404:Creatinine / Q000378:metabolism; D005260:Female; D005665:Furosemide / Q000494:pharmacology*; D006801:Humans; D007671:Kidney Concentrating Ability / Q000187:drug effects; D008297:Male; D008657:Metabolic Clearance Rate; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D012982:Sodium, Dietary / Q000008:administration & dosage* / Q000494:pharmacology; D014882:Water-Electrolyte Balance / Q000187:drug effects
D012982:Sodium, Dietary; D001127:Arginine Vasopressin; D005665:Furosemide; D009320:Atrial Natriuretic Factor; D012964:Sodium; D003404:Creatinine; D011188:Potassium